tetano
Editor, Senior Moderator
Clin Appl Thromb Hemost
. Jan-Dec 2021;27:10760296211013104.
doi: 10.1177/10760296211013104.
Clinical Features of COVID-19 Patients With Venous Thromboembolism
Kai Liang[SUP] 1 [/SUP], Ying Fu[SUP] 2 [/SUP], Yi Kang[SUP] 3 [/SUP], Huanzhang Shao[SUP] 4 [/SUP], Jianxu Yang[SUP] 4 [/SUP], Mingzhe Cui[SUP] 1 [/SUP], Shuiting Zhai[SUP] 1 [/SUP]
Affiliations
Abstract
This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in the 35 patients was 20.0%, occurring in severe (n = 1) and critical (n = 6) cases. D-dimer showed statistical significance in laboratory examination, representing except a diagnostic index and especial can be a prognostic factor in VTE among COVID-19 patients. Severe and critical COVID-19 cases had significantly reduced platelet counts, with a risk of hemorrhage. During treatment, the risk of both hemorrhage and thrombosis should be considered. VTE occurs in COVID-19 cases, affecting individuals with severe and critical symptoms. Significant D-dimer increase is of great significance in the risk assessment of death in critical cases of COVID-19. Appropriate measures should be taken to prevent VTE during treatment.
Keywords: COVID-19; incidence; pneumonia; venous thromboembolism.
. Jan-Dec 2021;27:10760296211013104.
doi: 10.1177/10760296211013104.
Clinical Features of COVID-19 Patients With Venous Thromboembolism
Kai Liang[SUP] 1 [/SUP], Ying Fu[SUP] 2 [/SUP], Yi Kang[SUP] 3 [/SUP], Huanzhang Shao[SUP] 4 [/SUP], Jianxu Yang[SUP] 4 [/SUP], Mingzhe Cui[SUP] 1 [/SUP], Shuiting Zhai[SUP] 1 [/SUP]
Affiliations
- PMID: 34169772
- DOI: 10.1177/10760296211013104
Abstract
This study aimed to assess the clinical features of coronavirus disease 2019 (COVID-19) patients with VTE, to help develop preventive measures for venous thromboembolism (VTE in COVID-19) cases. COVID-19 patients admitted to Henan Provincial People's Hospital were retrospectively analyzed, including 23, 4 and 8 cases with mild to moderate, severe and critical symptoms, respectively. VTE incidence, age at onset, relevant laboratory parameters and prognosis were analyzed. Overall, VTE incidence in the 35 patients was 20.0%, occurring in severe (n = 1) and critical (n = 6) cases. D-dimer showed statistical significance in laboratory examination, representing except a diagnostic index and especial can be a prognostic factor in VTE among COVID-19 patients. Severe and critical COVID-19 cases had significantly reduced platelet counts, with a risk of hemorrhage. During treatment, the risk of both hemorrhage and thrombosis should be considered. VTE occurs in COVID-19 cases, affecting individuals with severe and critical symptoms. Significant D-dimer increase is of great significance in the risk assessment of death in critical cases of COVID-19. Appropriate measures should be taken to prevent VTE during treatment.
Keywords: COVID-19; incidence; pneumonia; venous thromboembolism.